SCOPUS 정보 검색 플랫폼

Drug Discovery Today

Volumn 17, Issue 5-6, 2012, Pages 185-187

Collaborative approaches to anticancer drug discovery and development: A Cancer Research UK perspective

(3) Williams, Robert J a Walker, Ian a Takle, Andrew K a

a IMPERIAL CANCER RESEARCH FUND (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ABIRATERONE; ANTINEOPLASTIC AGENT; AT13148; AZD0424; AZD3965; CANCER VACCINE; CEN 209; DI B4; GSK1070916A; IMA950; TEMOZOLOMIDE; UNCLASSIFIED DRUG;

CANCER CHEMOTHERAPY; CANCER RESEARCH; CASTRATION RESISTANT PROSTATE CANCER; DRUG INDUSTRY; FUNDING; GLIOBLASTOMA; GOOD MANUFACTURING PRACTICE; HEMATOLOGIC MALIGNANCY; HUMAN; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); REVIEW; SOLID TUMOR; UNITED KINGDOM;

EID: 84862809512 PISSN: 13596446 EISSN: 18785832 Source Type: Journal
DOI: 10.1016/j.drudis.2012.01.020 Document Type: Short Survey

Times cited : (17)

References (17)

1
- 77951964134
- Business Insights Report
- Riley, S. (2011) The Pharmaceutical Market Outlook to 2018: Key Threats and Opportunities for Pharma and its Responses to Them, Business Insights Report
- (2011) The Pharmaceutical Market Outlook to 2018: Key Threats and Opportunities for Pharma and Its Responses to Them
- Riley, S.¹

2
- 79957889347
- The productivity crisis in pharmaceutical R&D
- F. Pammolli The productivity crisis in pharmaceutical R&D Nat. Rev. Drug Discov. 10 2011 428 438
- (2011) Nat. Rev. Drug Discov. , vol.10 , pp. 428-438
- Pammolli, F.¹

3
- 84862788038
- Bernstein Research
- J. Scannell The Long View: Pharma R&D Productivity - When the Cures Fail, it Makes Sense to Check the Diagnosis 2010 Bernstein Research
- (2010) The Long View: Pharma R&D Productivity - When the Cures Fail, It Makes Sense to Check the Diagnosis
- Scannell, J.¹

4
- 77649234756
- How to improve R&D productivity: The pharmaceutical industry's grand challenge
- S.M. Paul How to improve R&D productivity: the pharmaceutical industry's grand challenge Nat. Rev. Drug Discov. 9 2010 203 214
- (2010) Nat. Rev. Drug Discov. , vol.9 , pp. 203-214
- Paul, S.M.¹

5
- 78651297594
- The problem with today's pharmaceutical business - An outsider's view
- M. Kessel The problem with today's pharmaceutical business - an outsider's view Nat. Biotechnol. 29 2011 27 33
- (2011) Nat. Biotechnol. , vol.29 , pp. 27-33
- Kessel, M.¹

6
- 84879114558
- Cmr International CMR International
- CMR International CMR International 2011 Pharmaceutical R&D Factbook 2011 CMR International
- (2011) CMR International 2011 Pharmaceutical R&D Factbook

7
- 4344645978
- Can the pharmaceutical industry reduce attrition rates?
- I. Kola, and J. Landis Can the pharmaceutical industry reduce attrition rates? Nat. Rev. Drug Discov. 3 2004 711 715
- (2004) Nat. Rev. Drug Discov. , vol.3 , pp. 711-715
- Kola, I.¹ Landis, J.²

8
- 37649012447
- Development trends for new cancer therapeutics and vaccines
- J.M. Reichert, and J.B. Wenger Development trends for new cancer therapeutics and vaccines Drug Discov. Today 13 2007 30 37
- (2007) Drug Discov. Today , vol.13 , pp. 30-37
- Reichert, J.M.¹ Wenger, J.B.²

9
- 67649348042
- Roadmap for success in oncology
- F. Desdouits Roadmap for success in oncology Scrip Exec. Brief. 1 2008 1 11
- (2008) Scrip Exec. Brief. , vol.1 , pp. 1-11
- Desdouits, F.¹

10
- 79551575056
- Phase III and submission failures: 2007-2010
- J. Arrowsmith Phase III and submission failures: 2007-2010 Nat. Rev Drug Discov. 10 2011 87
- (2011) Nat. Rev Drug Discov. , vol.10 , pp. 87
- Arrowsmith, J.¹

11
- 79955601786
- Phase II failures: 2008-2010
- J. Arrowsmith Phase II failures: 2008-2010 Nat. Rev Drug Discov. 10 2011 328
- (2011) Nat. Rev Drug Discov. , vol.10 , pp. 328
- Arrowsmith, J.¹

12
- 79952160304
- Advances in the preclinical testing of cancer therapeutic hypothesis
- G. Caponigro, and W.R. Sellers Advances in the preclinical testing of cancer therapeutic hypothesis Nat. Rev. Drug Discov. 10 2011 179 187
- (2011) Nat. Rev. Drug Discov. , vol.10 , pp. 179-187
- Caponigro, G.¹ Sellers, W.R.²

13
- 77954028523
- Envisioning the future of early anticancer drug development
- T.A. Yap Envisioning the future of early anticancer drug development Nat. Rev. Cancer 10 2010 514 523
- (2010) Nat. Rev. Cancer , vol.10 , pp. 514-523
- Yap, T.A.¹

14
- 79959556142
- Drug buddies
- H. Ledford Drug buddies Nature 474 2011 433 434
- (2011) Nature , vol.474 , pp. 433-434
- Ledford, H.¹

15
- 79960980460
- Abiraterone acetate
- C.J. Logothetis Abiraterone acetate Nat. Rev. Drug Discov. 10 2011 573 574
- (2011) Nat. Rev. Drug Discov. , vol.10 , pp. 573-574
- Logothetis, C.J.¹

16
- 3042784503
- 17,20-lyase inhibitor abiraterone acetate (CB7630) in patients with prostate cancer
- 17,20-lyase inhibitor abiraterone acetate (CB7630) in patients with prostate cancer Br. J. Cancer 90 2004 2317 2325
- (2004) Br. J. Cancer , vol.90 , pp. 2317-2325
- O'Donnell, A.¹

17
- 78049457409
- Utilizing targeted cancer therapeutic agents in combination: Novel approaches and urgent requirements
- S. Kummar Utilizing targeted cancer therapeutic agents in combination: novel approaches and urgent requirements Nat. Rev. Drug Discov. 9 2010 843 856
- (2010) Nat. Rev. Drug Discov. , vol.9 , pp. 843-856
- Kummar, S.¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.